2 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 2 separate news trends connected to Antibody Therapy, spanning July 21, 2026 through August 4, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 13 article observations and 13 source signals, led by Health coverage. Use it to compare how individual events emerged, spread and changed over time.
Engineered bispecific antibodies are targeting B-cell lymphoma by simultaneously engaging tumor cells and activating macrophages to destroy them.
Researchers have developed a fully human antibody drug capable of halting the growth and metastasis of aggressive prostate cancer in lab models.